Home » Stocks » CVSI

CV Sciences, Inc. (CVSI)

Stock Price: $0.4300 USD -0.0320 (-6.93%)
Updated November 25, 3:59 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 43.01M
Revenue (ttm) 28.56M
Net Income (ttm) -19.68M
Shares Out 100.02M
EPS (ttm) -0.20
PE Ratio n/a
Forward PE 15.63
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 25
Last Price $0.4300
Previous Close $0.4620
Change ($) -0.0320
Change (%) -6.93%
Day's Open 0.4640
Day's Range 0.3960 - 0.4640
Day's Volume 1,031,108
52-Week Range 0.25 - 1.34

More Stats

Market Cap 43.01M
Enterprise Value n/a
Earnings Date (est) Apr 1, 2021
Ex-Dividend Date n/a
Shares Outstanding 100.02M
Float 96.05M
EPS (basic) n/a
EPS (diluted) -0.20
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 1.17
PE Ratio n/a
Forward PE 15.63
P/FCF Ratio n/a
PS Ratio 1.51
PB Ratio 2.30
Revenue 28.56M
Operating Income n/a
Net Income -19.68M
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin 122.87%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -22.59%
ROE -74.68%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$0.81*
(88.95% upside)
Low
0.55
Current: $0.4300
High
1.00
Target: 0.81
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name CV Sciences, Inc.
Country United States
Employees 118
CEO Joseph D. Dowling

Stock Information

Ticker Symbol CVSI
Stock Exchange US OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier OTCMKTS: CVSI

Description

CV Sciences operates as a life science company. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets hemp-based cannabidiol (CBD) products under the name of PlusCBD in a range of market sectors, including nutraceutical, beauty care, and specialty foods. It serves internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, master distributors, specialty retailers, and convenience stores, as well as food, drug, and mass merchandise retailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. Its products product candidates are based on proprietary formulations, processes, and technology. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.